146 related articles for article (PubMed ID: 34113784)
21. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
[TBL] [Abstract][Full Text] [Related]
22. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
23. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.
Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE
Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037
[TBL] [Abstract][Full Text] [Related]
24. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
[TBL] [Abstract][Full Text] [Related]
25. The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
Gottschalk WK; Mahon S; Hodgson D; Barrera J; Hill D; Wei A; Kumar M; Dai K; Anderson L; Mihovilovic M; Lutz MW; Chiba-Falek O
J Alzheimers Dis; 2023; 94(4):1563-1576. PubMed ID: 37458041
[TBL] [Abstract][Full Text] [Related]
26. Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain.
Lang AL; Eulalio T; Fox E; Yakabi K; Bukhari SA; Kawas CH; Corrada MM; Montgomery SB; Heppner FL; Capper D; Nachun D; Montine TJ
Acta Neuropathol Commun; 2022 Nov; 10(1):174. PubMed ID: 36447297
[TBL] [Abstract][Full Text] [Related]
27. The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
Babić Leko M; Jurasović J; Nikolac Perković M; Španić E; Sekovanić A; Orct T; Lukinović Škudar V; Bačić Baronica K; Kiđemet-Piskač S; Vogrinc Ž; Pivac N; Borovečki F; Hof PR; Šimić G
J Alzheimers Dis; 2021; 82(2):661-672. PubMed ID: 34057084
[TBL] [Abstract][Full Text] [Related]
28. The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age.
Ferencz B; Laukka EJ; Lövdén M; Kalpouzos G; Keller L; Graff C; Wahlund LO; Fratiglioni L; Bäckman L
Front Hum Neurosci; 2013; 7():198. PubMed ID: 23734114
[TBL] [Abstract][Full Text] [Related]
29. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.
Pomara N; Bruno D; Nierenberg JJ; Sidtis JJ; Martiniuk FT; Mehta PD; Zetterberg H; Blennow K
Neurochem Res; 2011 Jun; 36(6):1124-8. PubMed ID: 21455713
[TBL] [Abstract][Full Text] [Related]
30. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
[TBL] [Abstract][Full Text] [Related]
32. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN
Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755
[TBL] [Abstract][Full Text] [Related]
33. Multi-omics Characterization of Epigenetic and Genetic Risk of Alzheimer Disease in Autopsied Brains from two Ethnic Groups.
Ma Y; Reyes-Dumeyer D; Piriz A; Recio P; Mejia DR; Medrano M; Lantigua RA; Vonsattel JPG; Tosto G; Teich AF; Ciener B; Leskinen S; Sivakumar S; DeTure M; Ranjan D; Dickson D; Murray M; Lee E; Wolk DA; Jin LW; Dugger BN; Hiniker A; Rissman RA; Mayeux R; Vardarajan BN
medRxiv; 2024 Feb; ():. PubMed ID: 38405911
[TBL] [Abstract][Full Text] [Related]
34. TOMM40 polymorphism is associated with resting-state functional MRI results in patients with Alzheimer's disease.
Xiao X; Wei J; Zhang W; Jiao B; Liao X; Pan C; Liu X; Yan X; Tang B; Zhang Y; Wang D; Xing W; Liao W; Shen L
Neuroreport; 2019 Nov; 30(16):1068-1073. PubMed ID: 31568198
[TBL] [Abstract][Full Text] [Related]
35. Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.
Koo KYG; Schweizer TA; Fischer CE; Munoz DG
Curr Alzheimer Res; 2019; 16(3):243-250. PubMed ID: 30605058
[TBL] [Abstract][Full Text] [Related]
36. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.
Bekris LM; Galloway NM; Montine TJ; Schellenberg GD; Yu CE
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):409-417. PubMed ID: 19554612
[TBL] [Abstract][Full Text] [Related]
37. Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study.
Luo X; Qiu T; Xu X; Huang P; Gu Q; Shen Z; Yu X; Jia Y; Guan X; Song R; Zhang M;
J Alzheimers Dis; 2016; 50(4):1137-48. PubMed ID: 26836191
[TBL] [Abstract][Full Text] [Related]
38. Characterization of
Nishimura A; Nonomura H; Tanaka S; Yoshida M; Maruyama Y; Aritomi Y; Saunders AM; Burns DK; Lutz MW; Runyan G; Lai E; Budur K; Roses AD
Alzheimers Dement (N Y); 2017 Nov; 3(4):524-530. PubMed ID: 29124110
[TBL] [Abstract][Full Text] [Related]
39. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.
Bruno D; Pomara N; Nierenberg J; Ritchie JC; Lutz MW; Zetterberg H; Blennow K
Exp Gerontol; 2012 May; 47(5):347-52. PubMed ID: 21983493
[TBL] [Abstract][Full Text] [Related]
40. Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.
Ferencz B; Karlsson S; Kalpouzos G
Int J Alzheimers Dis; 2012; 2012():421452. PubMed ID: 22550605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
